Menu
Back to Journals » ImmunoTargets and Therapy » Volume 1
ESCI
SJR OA
CiteScore
Impact Factor
ImmunoTargets and Therapy
ISSN: 2253-1556
- View all (170)
- Volume 13, 2024 (15)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 1, 2012
Original Research
T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptor- stimulated macrophages
Walk RM, Elliot ST, Blanco FC, Snyder JA, Jacobi AM, Rose SD, Behlke MA, Salem AK, Vukmanovic S, Sandler AD
ImmunoTargets and Therapy 2012, 1:13-23
Published Date: 23 November 2012
Review
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S
ImmunoTargets and Therapy 2012, 1:7-12
Published Date: 12 October 2012
Editorial
Cancer as an immune-mediated disease
Shurin MR
ImmunoTargets and Therapy 2012, 1:1-6
Published Date: 14 June 2012